0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Viewpoint |

The Reach of the 340B Drug Pricing Program

Joerg Albrecht, MD, PhD1,2; Sukhraj Mudahar, PharmD, BCPS3
[+] Author Affiliations
1Division of Dermatology, Department of Medicine, John H. Stroger Jr Hospital of Cook County, Chicago, Illinois
2Department of Dermatology, Rush University Medical Center, Chicago, Illinois
3Department of Pharmacy, John H. Stroger Jr Hospital of Cook County, Chicago, Illinois
JAMA Dermatol. 2015;151(9):923-924. doi:10.1001/jamadermatol.2015.1005.
Text Size: A A A
Published online

Extract

This Viewpoint discusses the 304B drug pricing program and how institutions can use the program to make medications available to uninsured patients.

Drugs are expensive, and providing them to underinsured or uninsured patients is difficult. To reduce costs for primarily tax-funded drug providers, the federal government created the relatively obscure 340B drug pricing program in 1992. This program applies only to outpatient medications and is available to nonprofit or public hospitals or clinics that meet the criteria for serving a disproportionate share of low-income patients. More than 20 years later, 340B pricing is available to 18 215 health care facilities in the United States, including one-third of all hospitals,1 not all of which may be interested in charity care. Despite the broad distribution of the plan, only 2% of all drugs purchased in the United States fall under 340B discounts.2

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

493 Views
0 Citations
×

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
Jobs
brightcove.createExperiences();